Skip to main content

Atezolizumab / Hyaluronidase Side Effects

Applies to atezolizumab / hyaluronidase: subcutaneous solution.

Important warnings This medicine can cause some serious health issues

Atezolizumab and hyaluronidase affects your immune system and may cause it to attack normal healthy tissues or organs, leading to serious or life-threatening medical problems.

Call your doctor at once if you have new or worsening symptoms such as: chest pain, cough, breathing problems, stomach pain, vomiting, changes in appetite or weight, increased thirst or urination, painful urination, headaches, neck stiffness, vision problems, tiredness, mood changes, muscle weakness, hair loss, feeling cold, bleeding or bruising, diarrhea, bloody or tarry stools, dark urine, or yellowing of the skin or eyes.

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Some side effects may occur during the injection. Tell your medical caregivers if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Call your doctor at once if you have:

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

For healthcare professionals

Applies to atezolizumab / hyaluronidase: subcutaneous solution.

General adverse events

Adverse reactions described here are compiled from clinical studies across all indications in which atezolizumab was administered IV or subcutaneously as monotherapy or in combination with other therapies.

The most common adverse effects occurring in 60% of patients or greater across all studies and formulations were rash, anemia, decreased lymphocytes, decreased hemoglobin, neutropenia, thrombocytopenia, lymphopenia, decreased platelets, decreased albumin, increased AST/ALT, neutralizing antibodies, hyperglycemia, decreased phosphorus, musculoskeletal pain/myalgia, increased creatine kinase, increased triacylglycerol lipase, increased alkaline phosphatase, and fatigue/asthenia.[Ref]

Cardiovascular

Arrhythmia includes atrial fibrillation, sinus bradycardia, ventricular tachycardia, and sinus tachycardia.

Dermatologic

Rash includes dermatitis, genital rash, skin exfoliation, maculo-papular rash, erythematous rash, papular rash, lichen planus, eczema asteatotic, exfoliative dermatitis, palmar-plantar erythrodysesthesia syndrome, dyshidrotic eczema, eczema, drug eruption, pruritic rash, toxic skin eruption, dermatitis acneiform, and pemphigoid.

Endocrine

Gastrointestinal

Stomatitis includes mucosal inflammation, aphthous ulcer, mouth ulceration, cheilitis and glossitis.

Hematologic

Hemorrhage includes pulmonary hemorrhage, hemoptysis, conjunctival hemorrhage, epistaxis, hematuria, rectal hemorrhage, and laryngeal hemorrhage.

Fatal and other serious complications can occur in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1 blocking antibody.

Hepatic

Hepatoxicity includes increased ALT/AST, increased bilirubin, hepatitis, increased hepatic enzyme, hepatocellular injury, hyperbilirubinemia, increased/abnormal liver function test increased, hepatic failure, and fulminant hepatitis.

Immunologic

Local

Metabolic

Musculoskeletal

Musculoskeletal pain/myalgia includes bone pain, back pain, spinal pain, musculoskeletal chest pain, pain in extremity, neck pain, non-cardiac chest pain, musculoskeletal discomfort, and musculoskeletal stiffness.

Nervous system

Peripheral neuropathy includes paraesthesia, peripheral sensory neuropathy, hypoesthesia, polyneuropathy, dysesthesia, neuralgia, and axonal neuropathy.

Ocular

Other

Edema includes peripheral edema, lymphoedema, face edema, eyelid edema, periorbital edema, lip edema and generalized edema.

Psychiatric

Renal

Respiratory

References

1. (2024) "Product Information. Tecentriq Hybreza (atezolizumab-hyaluronidase)." Genentech

Further information

Atezolizumab/hyaluronidase side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.